Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 5, 2000, Pages 1443-1446

  Lee, Nancy ^a   Fawaaz, Rashid ^a   Olsson, Carl A ^a   Benson, Mitchell C ^a   Petrylak, Daniel P ^a   Schiff, Peter B ^a   Bagiella, Emilia ^b   Singh, Arun ^a   Ennis, Ronald D ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Bone scan; Prostate cancer; Radionuclide bone scan; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; RADIOISOTOPE;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; TUMOR BIOPSY;

ANALYSIS OF VARIANCE; BONE AND BONES; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0034564298     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00785-9     Document Type: Article

References (17)

1. Annual report to the nation on the status of cancer, 1973-1996; With a special section on lung cancer and tobacco smoking
2. Risk factors for prostate cancer
3. The role of bone scanning in the assessment of prostatic carcinoma
4. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer; A multiinstitutional update
5. The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer
6. Which patients with prostatic carcinoma require a staging bone scan?
7. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?
8. The clinical value of prostate-specific antigen and bone scintigrapy in the staging of patients with newly diagnosed, pathologically proven prostate cancer
9. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer; Prostate specific antigen is superior to all other clinical parameters
10. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer
11. An analystical comparison of the three most commonly used prostate specific antigen assays; Tandem-R., Tandem-E, and IMX
12. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate
13. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line
14. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential
15. Practice trends in the diagnosis and management of prostate cancer in the United States
16. A nationwide survey of practicing urologists; current management of benign prostatic hyperplasia and clinically localized prostate cancer